Heart failure means your heart isn't pumping or filling with blood as efficiently as your body needs — it doesn't mean your heart has stopped working. It comes in two main types, defined by your ejection fraction (EF), the percentage of blood your left ventricle pumps out with each heartbeat: HFrEF (heart failure with reduced ejection fraction — in plain terms, a heart with weak contraction, ejection fraction under 40%) and HFpEF (heart failure with preserved ejection fraction — in plain terms, a heart with stiff, preserved contraction, ejection fraction 50% or higher). Both are serious, lifelong conditions — but both also have real, effective treatments, and with today's medications most people can feel significantly better and live longer, more active lives than a generation ago.
What Is Heart Failure?
"Heart failure" is an umbrella term for the heart not meeting the body's needs — which can happen for two very different underlying reasons. In HFrEF, the pumping chamber itself has weakened, so it squeezes out less blood than it should (a low EF, usually below 40%). In HFpEF, the pumping strength is normal, but the heart muscle has become stiff and doesn't relax and fill with blood properly between beats (a normal EF, generally 50% or higher, that doesn't tell the whole story). Either way, blood and fluid can back up into your lungs and body, which is why both types cause similar symptoms like shortness of breath and swelling — but the two are diagnosed and treated somewhat differently, which is why it's worth understanding which one you have.
HFrEF: The "Weak" Heart
Think of your heart's main pumping chamber (the left ventricle) like a rubber ball you squeeze to push out water. In HFrEF, that "ball" has become weaker and stretched out, so each squeeze pushes out less water than it should — a healthy heart pumps out about 55–70% of the blood in it with each beat, while in HFrEF that number drops below 40%. Common causes include a prior heart attack, long-standing high blood pressure, heart valve problems, viral infections of the heart muscle, or, in some cases, no clear cause is ever found.
HFpEF: The "Stiff" Heart
In HFpEF, the heart muscle becomes stiffer than normal, so it doesn't relax fully between beats. Pressure backs up into the lungs and body even though the heart is still squeezing out a normal percentage of blood with each beat — a "stiff, not weak" heart. HFpEF is closely linked to hypertension (long-standing high blood pressure is the most common contributor), obesity and metabolic syndrome, diabetes, older age, and atrial fibrillation. It sometimes overlaps with other conditions like cardiac amyloidosis (worth ruling out, especially in older patients with unexplained thickened heart walls) or hypertrophic cardiomyopathy. HFpEF is often under-recognized precisely because the pumping number looks fine — but it's just as real and just as important to treat as HFrEF.
Healthy Heart
Pumps out ~55–70% of its blood with each beat (normal EF)
HFrEF Heart — "Weak"
Pumps out less than 40% with each beat — the muscle itself has weakened
HFpEF Heart — "Stiff"
Still pumps out a normal percentage, but the thickened, stiff walls (dashed outline) don't relax and fill properly between beats
Common Symptoms
Both types tend to cause a similar pattern:
- Shortness of breath, especially lying flat, with activity, or (in HFpEF) with exertion
- Swelling in the legs, ankles, or belly
- Fatigue or feeling unusually tired, and reduced exercise tolerance
- Rapid weight gain over a few days (fluid retention)
- A persistent cough or wheeze
- Waking up short of breath at night
How It's Diagnosed
Your doctor combines your symptoms and exam with an echocardiogram — an ultrasound of the heart that measures your ejection fraction and shows whether it's reduced (HFrEF) or preserved alongside signs of stiff, poor relaxation (HFpEF). Blood tests (including a marker called BNP or NT-proBNP), a chest X-ray, and sometimes a cardiac MRI or catheterization help find the underlying cause. For HFpEF specifically, the diagnosis isn't always obvious from resting tests alone, so specialized testing (exercise-based echo or catheterization) and evaluation for amyloidosis are sometimes added. (See Cardiac Amyloidosis, Cardiac Testing & Imaging, and Lab Tests & Diagnostics.)
Treating HFrEF: The "Four Pillars"
The good news: HFrEF has more effective treatments than almost any other area of cardiology. Most patients end up on a combination of four medication classes, often called "the four pillars" of heart failure therapy — each one shown to help people live longer and feel better. (See Heart Failure Medications: The Four Pillars for the full picture of how these four work together, and why your doctor usually aims for all four rather than just one or two.)
- Beta-Blockers
- ARNI / ACE Inhibitors / ARBs
- MRAs (Mineralocorticoid receptor antagonists)
- SGLT2 Inhibitors
Diuretics ("water pills") help manage fluid buildup and symptoms. Some patients also benefit from a defibrillator (ICD) or a biventricular pacemaker (CRT) — small devices placed under the skin that protect against dangerous heart rhythms or help the heart pump more in sync. For patients who don't improve with medications, options like LVAD therapy or heart transplant evaluation may be discussed — this is a small subset of patients, and your cardiologist will guide you if this becomes relevant.
Treating HFpEF
SGLT2 inhibitors have specific proven benefit in HFpEF too — a newer and important development, though the specific "four pillar" combination proven for HFrEF isn't proven the same way here. Diuretics help with symptom and fluid management. Aggressive treatment of contributing conditions — blood pressure, weight, diabetes, atrial fibrillation — matters more here than in HFrEF, since these are often the actual drivers of the disease. GLP-1 medications have also shown real benefit specifically in HFpEF associated with obesity. (See GLP-1 Medications: A Complete Guide.)
Monitoring Ejection Fraction & NT-proBNP Over Time
EF isn't just a one-time number from your diagnosis — it's typically followed over time with repeat echocardiograms, especially in HFrEF, to see how the heart is responding to treatment. With consistent "four pillar" therapy, a large portion of HFrEF patients see their EF improve over months, and some improve enough that their heart failure gets reclassified as "HFrEF with improved EF." That's genuinely good news, but it's not considered "cured" — current guidance is to continue your medications even after EF recovers, since stopping often causes it to decline again.
NT-proBNP (and its related marker, BNP) is a blood test that measures a hormone your heart releases when its walls are stretched or under strain. It tends to rise when heart failure is worsening — from fluid buildup, decompensation, or a new stress on the heart — and tends to fall with effective treatment. Trending your NT-proBNP over time, alongside your symptoms and exam, helps your care team gauge whether therapy is working; a rising trend can be an early warning sign even before symptoms clearly worsen, while a stable or falling trend is reassuring.
EF and NT-proBNP reflect related but distinct things: EF is an imaging-based measurement of pumping function, while NT-proBNP is a real-time biochemical signal of wall stress and fluid status. They generally move in the same general direction — EF improving tends to come with falling NT-proBNP, and decompensation tends to raise NT-proBNP — but they don't track perfectly together. NT-proBNP can rise with a viral illness, a change in kidney function, or atrial fibrillation even without true worsening of pump function, and it can run higher at baseline in older or heavier patients for reasons unrelated to heart failure severity. This is why your care team interprets the trend in both numbers together with your overall clinical picture, rather than reading either one alone.
Both markers carry real prognostic weight: a persistently low EF or a persistently high or rising NT-proBNP are, in general, associated with higher risk of hospitalization and disease progression over time, while EF improvement and a falling NT-proBNP trend on treatment are reassuring signs generally associated with a better long-term outlook. This is especially relevant in HFpEF, where EF is normal by definition and so doesn't help distinguish a stable patient from a worsening one — which is exactly why NT-proBNP and symptom tracking carry extra weight in HFpEF monitoring.
Lifestyle Changes That Help
- Watch your salt intake — sodium causes your body to hold onto fluid, which matters for both types
- Weigh yourself daily — a jump of 3+ lbs in a day or 5+ lbs in a week can mean fluid retention; call your care team (use the Daily Symptom & Weight Tracker to make this easy to keep up with)
- Stay active — supervised cardiac rehab or regular walking, once cleared by your doctor, genuinely helps both types
- Limit alcohol, and avoid recreational drugs that stress the heart
- Take your medications every day, even when you feel well — they're doing their job
- Weight management is particularly impactful in HFpEF given its strong link to obesity
- Blood pressure control matters for both, but is often a central driver specifically in HFpEF
Living With It
Many people are surprised to learn how much medication has changed heart failure care. With consistent treatment, a large portion of HFrEF patients see their ejection fraction improve over time. HFpEF is generally a chronic condition managed long-term, and because it's so closely tied to other conditions (hypertension, obesity, diabetes), treating those conditions well is central to treating HFpEF itself — not a separate side project. Either way, heart failure is a condition you manage, often for the rest of your life — but "manage" increasingly means living fully, working, traveling, and staying active.
When to Call Your Doctor vs. Go to the ER
- You've gained 3+ lbs overnight or 5+ lbs in a week
- Increasing swelling or shortness of breath with usual activity
- New or worsening cough
- Severe shortness of breath at rest
- Chest pain or pressure
- Fainting or feeling like you might pass out
- A racing or irregular heartbeat that doesn't stop
(See When to Go to the ER vs. Call vs. Wait for a fuller symptom-by-symptom guide covering these and other situations.)
Common Questions
If my ejection fraction is normal, how can I have heart failure?
Because "heart failure" describes the heart not meeting the body's needs, which can happen from a pumping problem (HFrEF) or a filling/relaxation problem (HFpEF) — the EF number alone doesn't tell the whole story.
Are HFpEF treatments the same as HFrEF?
Overlapping but distinct — the specific "four pillar" combination proven for HFrEF isn't proven the same way for HFpEF, though SGLT2 inhibitors and treating contributing conditions are central to both.
Could this actually be amyloidosis?
Worth asking your doctor, especially if you're an older patient with unexplained thickened heart walls — it's specifically screened for in appropriate HFpEF workups now.
Will I need a transplant?
Most people with heart failure never need a transplant or LVAD — those are reserved for a small subset whose heart failure doesn't respond to full medical therapy.
Can I exercise if I have heart failure?
Yes — for most patients, supervised exercise is one of the most helpful things you can do, not something to avoid.
Why do I need four medications if I feel fine?
Because these medications don't just treat symptoms — they change the underlying disease process. Feeling fine is often a sign the medications are working, not a reason to stop them.
Is this reversible?
Sometimes, partially or fully — especially in HFrEF, where many patients see meaningful EF improvement with consistent treatment (see "Monitoring Ejection Fraction & NT-proBNP Over Time" above). It depends heavily on the cause and how consistently treatment is followed.
What's my target daily fluid and sodium intake?
This is individualized — ask your care team for your specific numbers rather than assuming a general guideline applies, and see Heart-Healthy Eating for practical counting methods and example food lists for both.